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Abstract
Background: Oxygen deficiency in tumor tissue is associated with a malign phenotype, characterized by high
invasiveness, increased metastatic potential and poor prognosis. Hypoxia chambers are the established standard
model for in vitro studies on tumor hypoxia. An enzymatic hypoxia system (GOX/CAT) based on the use of glucose
oxidase (GOX) and catalase (CAT) that allows induction of stable hypoxia for in vitro approaches more rapidly and
with less operating expense has been introduced recently. Aim of this work is to compare the enzymatic system
with the established technique of hypoxia chamber in respect of gene expression, glucose metabolism and
radioresistance, prior to its application for in vitro investigation of oxygen deficiency.
Methods: Human head and neck squamous cell carcinoma HNO97 cells were incubated under normoxic and
hypoxic conditions using both hypoxia chamber and the enzymatic model. Gene expression was investigated using
Agilent microarray chips and real time PCR analysis.
14C-fluoro-deoxy-glucose uptake experiments were performed in
order to evaluate cellular metabolism. Cell proliferation after photon irradiation was investigated for evaluation of
radioresistance under normoxia and hypoxia using both a hypoxia chamber and the enzymatic system.
Results: The microarray analysis revealed a similar trend in the expression of known HIF-1 target genes between
the two hypoxia systems for HNO97 cells. Quantitative RT-PCR demonstrated different kinetic patterns in the
expression of carbonic anhydrase IX and lysyl oxidase, which might be due to the faster induction of hypoxia by
the enzymatic system.
14C-fluoro-deoxy-glucose uptake assays showed a higher glucose metabolism under hypoxic
conditions, especially for the enzymatic system. Proliferation experiments after photon irradiation revealed
increased survival rates for the enzymatic model compared to hypoxia chamber and normoxia, indicating
enhanced resistance to irradiation. While the GOX/CAT system allows independent investigation of hypoxia and
oxidative stress, care must be taken to prevent acidification during longer incubation.
Conclusion: The results of our study indicate that the enzymatic model can find application for in vitro
investigation of tumor hypoxia, despite limitations that need to be considered in the experimental design.
Background
Reduced oxygen levels are measured in several solid
tumors mainly as result of tumor outgrowing the exist-
ing vasculature but also as result of structural and func-
tional disturbances of tumor vasculature [1]. In
particular, tumor blood vessels that are newly formed
during angiogenesis are highly irregular and possess
incomplete endothelial linings and basement mem-
branes, as well as arteriovenous shunts, resulting in dis-
turbances of blood flow and oxygen delivery [2]. Tumor
hypoxia is associated with a more aggressive neoplastic
phenotype, characterized by high invasiveness and
increased metastatic potential. Genes with key-role in
metastatic processes, such as lysyl oxidase (LOX), met
proto-oncogene (MET) and c-X-c chemokine receptor 4
(CXCR4) have been identified to be upregulated under
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and prognosis, hypoxic regions within a solid tumor are
characterized by increased resistance towards che-
motherapy or radiotherapy. In particular, oxygen defi-
ciency upregulates the expression of the multidrug
resistance gene (MDR1), leading to efflux of chemother-
apeutic drugs [5]. In respect to radiation therapy both
chemical and biological mechanisms are found to be
important for increased radioresistance. Oxygen defi-
ciency disturbs the radiolysis of H2O leading to reduced
production of reactive species that are cytotoxic [6].
Furthermore, hypoxia promotes the activation of the
hypoxia inducible factor-1 (HIF-1), a heterodimeric tran-
scription factor that upregulates the expression of genes
involved in angiogenesis and tumorigenesis [7].
The fact that tumor hypoxia is associated with
increased therapy resistance and poor prognosis reveals
the necessity for extensive and detailed investigation of
biological mechanisms associated with oxygen defi-
ciency. The established method for in vitro investigation
of tumor hypoxia is the exposure of cultured cells to
defined, oxygen deficient gaseous environments. The
most common apparatus used for this purpose is the
hypoxia chamber. However this approach has critical
limitations, mainly in regard to oxygen diffusion and
equilibration. In particular, within a hypoxia chamber
oxygen reaches the cell surface after a protracted pro-
cess, including transport in the chamber, passing
through the material of the cell culture plate, solubility
depended entering the culture medium at the gas-
medium interface and diffusion through the medium to
the cell surface. Oxygen transport kinetic studies in the
past have revealed required time periods of about 30
min for equilibration of pO2 between the gas inside and
outside of the culture plate and more than 3 h for equi-
libration of the pO2 between the medium inside the
plate and the gas outside of it [8].
Recently an alternative way to generate in vitro
oxygen-deficient conditions has been evaluated [9,10].
This system is based on the use of the enzymes glucose
oxidase (GOX) and catalase (CAT). Addition of glucose
oxidase into the cell culture medium removes oxygen by
oxidizing glucose. The reaction leads to generation of
hydrogen peroxide, which is then removed by catalase,
in order to prevent cytotoxic effects due to accumula-
tion. This enzymatic system was found to induce rapid
depletion of oxygen within minutes at a defined rate.
Oxygen concentration in the cultured medium is
reported to be dependent by two factors: the activity of
glucose oxidase and the medium volume. GOX activity
has an influence on the depletion rate of oxygen, while
medium volume affects the diffusion distance of oxygen
from gas-medium interface to the cells. Experiments
have revealed that at defined GOX activity and medium
volume, controlled oxygen depletion can be achieved
and also stably maintained for at least 12-24 h [10].
Aim of the present work is to investigate the effects of
rapidly induced hypoxia on cellular processes using the
enzymatic GOX/CAT system in comparison to the estab-
lished method of hypoxia chamber. Since hypoxia is
known to be a feature of human head and neck squa-
mous cell carcinoma [11], the HNSCC cell line HNO97
was chosen for investigation under normoxic and
h y p o x i cc o n d i t i o n su s i n gah y p o x i ac h a m b e ra n dt h e
enzymatic model. We focused on three aspects: gene
expression, glucose metabolism and radioresistance.
Gene expression was investigated using Agilent microar-
ray chip analysis and real time PCR. Cellular glucose
metabolism was assessed with
14C-FDG uptake assays
and proliferation experiments after photon irradiation
were carried out for investigation of hypoxia induced
radioresistance. The results of our study indicate that the
enzymatic GOX/CAT system is an attractive alternative
technique for in vitro investigation of tumor hypoxia.
Methods
Cell culture
The human head and neck squamous cell carcinoma
cell line HNO97 [12] was cultivated in Dulbecco’s Mod-
ified Eagle’s Medium (DMEM containing 4.5 g/L glucose
and 58 ng/L L-glutamine but no sodium pyruvate) sup-
plemented with 10% (v/v) fetal calf serum (Gibco, Invi-
trogen Life Technologies) at 37°C in a 5% CO2
incubator.
In vitro enzymatic and non-enzymatic hypoxia induction
Enzymatic hypoxia
Hypoxia medium was prepared by diluting glucose oxi-
dase and catalase at a constant 1:10 ratio in cell culture
medium (both Sigma cat. No. C3155 and G0543).
Enzyme activities of stock solutions were 3 mM/s for
GOX and 998 s
-1 for CAT. To obtain a defined, stable
oxygen concentration of 2% on cell surface stock solu-
tions were diluted by 1:10,000 for GOX and 1:1,000 for
CAT. The medium volumes used were 2.5 ml for 6-well
plates and 10.63 ml for 10 cm cell culture plates and
the cells were incubated at 37°C. Previous experiments
using a computer-driven oxygen electrode Oxi 325-B
(WTW, Weilheim, Germany) for oxygen measurement
have revealed that at those conditions 2% hypoxia was
rapidly induced within 15 min and maintained over
24 h [10]. For incubation periods longer than 24 h med-
ium was replaced by pre-equilibrated hypoxic medium
to maintain nutrients and substrates such as glucose.
Hypoxia chamber
Cells cultivated in 6-well plates or 10 cm cell culture
dishes under a layer of exactly 2.5 ml and 10.63 ml cell
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chamber. The chamber was flushed with 2% O2/5%
CO2/93% N2 gas mixture for 5 min, sealed and kept
at 37°C. For longer incubation periods the chamber
was refilled after 24 h to ensure constant oxygen
concentrations.
Real time quantitative PCR
Total cellular RNA was isolated from confluent head
and neck squamous cell carcinoma HNO97 cells using
Trizol (TRIzol Reagent, Invitrogen #15596-018) accord-
ing to manufacturer instructions. RNA concentration
was measured with a NanoDrop spectrophotometer
(ND-1000 PeqLab Biotechnologie GmbH, Germany).
500 ng was transcribed into DNA using M-MLV reverse
transcriptase, 50 pmol random hexamer and 100 pmol
of oligo(dT) primers (Promega, Madison, WI, USA).
Quantification of relative mRNA transcript levels of
human carbonic anhydrase IX (CA9) and lysyl oxidase
(LOX) was performed on a StepOnePlus™ Real-Time
PCR System (Applied Biosystems), applying the TaqMan
methodology. Normalization was performed using B2
microglobulin (B2M) as endogenous control. Primers
were obtained from Applied Biosystems (Foster City,
CA, USA).
Gene expression
Gene expression of HNO97 cells under normoxic and
hypoxic conditions was investigated using whole human
genome microarrays. Total RNA from time points t = 0,
and after 24 h incubation under hypoxic conditions (2%
O2) using the hypoxia chamber and the GOX/CAT sys-
tem was investigated. To determine the influence of cell
density on gene expression, microarray analysis was also
performed for RNA isolated from cells incubated for the
same time period (24 h) under normoxic conditions. For
bioinformatical-analysis a step-wise approach was
applied: Weak signals, below the intensity of spike-in
linearity, were excluded, quantile normalization was per-
formed on background-subtracted signal intensities,
ratios were calculated by arithmetic mean normalization
of control group (t = 0 or normoxia t = 24 h) versus all
samples. Afterwards Log2 of ratios was calculated.
Microarray processing and data extraction
Genome-wide expression profiling was carried out using
whole human genome 4 × 44 k oligo microarrays (Agi-
lent, G4112F). Linear amplification from 500 ng total
RNA and spike-in-controls (Agilent #5188-5282) was
performed using the Agilent “Low RNA Input Linear
Amplification Kit Plus, one colour” (#5188-5339). Dur-
ing this process the amplified RNA was directly labelled
by incorporation of Cy3-labelled CTP. Labelled RNA
was purified with “RNeasy” mini spin columns (Qiagen
#74104) and 1.65 μg labelled RNA was used for chemi-
cal fragmentation and hybridisation (Gene expression
hybridization kit, Agilent #5188-5242). Assembly of the
gasket/slide-sandwich in the hybridisation chamber
(Agilent, #G2534A) was performed according to manu-
facturer instructions. For hybridisation, slide-sandwiches
were rotated at 10 rpm and 65°C for 16 h. Slides were
washed 1 min in GE Wash Buffer 1 at RT, 1 min in GE
Wash Buffer 2 at RT (Agilent, #5188-5325, 5188-5326)
and 30 sec in Acetonitril at RT on a magnetic stirrer.
Slides were scanned in an Agilent Microarray Scanner.
Data extraction of the resulting array images was per-
formed using the “Feature Extraction” software (Agilent,
Version 9.1) and SUMO (Christian Schwager, http://
angiogenesis.dkfz.de/oncoexpress/software/sumo/) was
used for statistical analysis, two-class t-tests and GO-
analysis. Pathway analysis was performed based on
information available on cellular signalling processes
from a curated database on signalling networks and sys-
tems biology package (Metacore, Genego, St Joseph, MI,
USA, http://www.genego.com).
FDG uptake
After trypsinisation 5 × 10
4 HNO97 cells were seeded in
6-well plates. Cells were incubated in DMEM + 10%
FCS for 24 h. Medium was removed and the cells were
incubated for 6 h and 24 h under normoxic and hypoxic
conditions (2% O2), using the enzymatic GOX/CAT sys-
tem and a hypoxia chamber. Subsequently, FDG uptake
experiments were performed in glucose-free DMEM
medium as described in the literature [13]. In particular,
after 30 min of pre-incubation in glucose-free medium,
37 kBq 2-fluoro-2-deoxy-D-[U-14C] glucose (FDG;
Amersham-Buchler; specific activity 10.8 GBq/mmol;
radioactive concentration 7.4 MBq/ml; radiochemical
purity 99.3%) per ml medium and cold FDG were added
to a final concentration of 0.1 mM. Cells were incubated
for 10 min with radioactive FDG and thereafter the
medium was removed and the cells were washed three
times with ice-cold PBS. Cells were then lysed on ice
with 1M NaOH. The lysates were counted on a scintilla-
tion counter. The viable cell number was determined by
a Vi-Cell™ XR Cell Viability Analyzer (Beckman Coul-
ter). Radioactive FDG uptake was calculated as %
applied dose per 10
6 cells. The experiment was per-
formed in triplicate and repeated twice.
Cell viability
50,000 human head and neck squamous cell carcinoma
HNO97 cells were seeded in 6-well plates and incubated
overnight at standard conditions and subsequently for
24 h under normoxia and hypoxia (2% O2) using both
the enzymatic GOX/CAT system and a hypoxia cham-
ber. Thereafter, cells were trypsinized and their viability
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assays using a Vi-Cell™ XR Cell Viability Analyzer
(Beckman Coulter).
Cell irradiation and proliferation assay
Proliferation assays were performed as described in the
literature [14]. 50,000 human head and neck squamous
cell carcinoma HNO97 cells were seeded in 6-well plates
and incubated overnight at standard conditions. The
cells were then incubated for 24 h at normoxic and
hypoxic conditions using both the enzymatic GOX/CAT
system and a hypoxia chamber. Irradiation with 6 MV
X-rays (Mevatron Siemens) at a dose of 4 Gy was per-
formed and further incubation for 72 h at the same con-
ditions as before irradiation was carried out. Thereafter
the cells were trypsinized and counted with a Vi-Cell™
XR Cell Viability Analyzer (Beckman Coulter). Non-
irradiated cells were incubat e da tt h es a m ec o n d i t i o n s .
The ratio vital irradiated/non-irradiated cells, which
represents the proportion of vital cells after irradiation,
compared to the non-irradiated control was calculated.
Statistical analysis
Statistical analysis of the genomics was performed with
SUMO (Christian Schwager, http://angiogenesis.dkfz.de/
oncoexpress/software/sumo/) using two-class t-tests.
Data of FDG-uptake and cell proliferation assays were
analyzed employing the Student t-test. Significance was
assumed at p < 0.05.
Results
Expression profiling
After 24 h incubation in a hypoxia chamber and with
the GOX/CAT system the expression of known and
validated HIF-1 target genes as described in the litera-
ture [15] was evaluated for HNO97 cells. The experi-
ments demonstrated a similar trend in the expression of
known HIF-1 target genes for both systems (Figure 1).
An overview of the expression of known HIF-1 target
genes for HNO97 cells is presented in Additional file 1.
In order to identify the strongest regulated genes for
HNO97 cells under hypoxia, a 2-class t-test was per-
formed. The 50 strongest regulated genes and the
respective p-values for the GOX/CAT system and the
hypoxia chamber compared to normoxic cells at 24 h
are presented in Figure 2A. Among them 7 genes are
known HIF-1 target genes (CA9, PGK1, ALDOC,
COL5A1, FN1, VEGF, ENO2), while 4 further genes are
described to be associated with hypoxia (AKR1C3,
ICAM1, LOXL2, LAMA3).
Differentially regulated genes between the two
hypoxic systems in HNO97 cells were identified per-
forming a two-class t-test after normalization against
Figure 1 Transcriptomics from HNO97 head and neck
squamous cell carcinoma cells under normoxia and hypoxia.
Gene expression pattern of known and validated HIF-1 target genes
[15] before and after 24 h incubation under normoxic and hypoxic
conditions (2% O2) using the enzymatic GOX/CAT system and a
hypoxia chamber. The colour scale encodes differential regulation of
genes from green (≤- 2-fold downregulated vs. reference normoxia
t = 0 RNA) to red (≥+ 2-fold upregulated vs. reference normoxia t =
0 RNA).
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The statistical analysis revealed the 50 strongest differ-
entially regulated genes (Figure 2B). Among them only
1g e n ew a sf o u n dt ob eaH I F - 1t a r g e t( C X C R 4 ) .
Functional groups of hypoxia regulated genes for both
systems were identified by assigning them to biological
function GO-terms. The most probably regulated GO-
Term was Glycolysis (p = 4 × E-5), which is shown in
Figure 3.
RT-PCR
In addition to microarray analysis (Additional file 1),
quantification of the tumor hypoxia regulated genes
CA9 and LOX was performed with real time PCR. To
evaluate the gene expression under hypoxic conditions
over time, HNO97 cells were incubated for time periods
of 4 h, 8 h and 24 h under normoxic conditions, in the
hypoxia chamber and with the GOX/CAT system. The
RT-PCR experiments demonstrated an upregulation of
the tumor hypoxia dependent genes for both systems (p
<0 . 0 5 ) .H o w e v e r ,t i m ek i n e t i co ft h eg e n ee x p r e s s i o n
was different between the slow hypoxia chamber and
the rapid hypoxia GOX/CAT system. In particular, the
highest level of CA9 and LOX expression was shown at
8 h incubation for the enzymatic system and then
decreased, while a continuous increase over time for the
incubation period was identified for the hypoxia cham-
ber (Figure 4).
FDG uptake
Fluorodeoxyglucose (FDG) uptake experiments were
carried out in order to evaluate the influence of hypoxia
in the metabolic activity of HNO97 cells. For these
experiments cells were cultivated under normoxia or
hypoxia (2% O2) for 6 h and 24 h and subsequently
radioactive FGD was shortly applied on the cells and the
uptake was determined. These studies demonstrated an
enhanced FDG uptake under hypoxia. After 6 h cultiva-
tion the FDG uptake was significantly increased for the
GOX/CAT system (p < 0.05). In regard to the hypoxia
chamber, only a slight increase was noticed compared to
normoxia (Table 1). After 24 h cultivation a significant
Figure 2 Strongest and differentially regulated genes. (A) Strongest regulated genes in HNO97 cells under hypoxia and respective p-values.
(B) Differentially regulated genes between the GOX/CAT system and hypoxia chamber in HNO97 cells and respective p-values. The colour scale
encodes differential regulation of genes from green (downregulated vs. reference normoxia t = 24 RNA) to red (upregulated vs. reference
normoxia t = 24 RNA).
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systems compared to normoxia (p < 0.05). Still, the
enhancement of FDG uptake was higher for the rapid
hypoxia inducing enzymatic model (p < 0.05) compared
to the slower hypoxia inducing chamber (Figure 5). The
ratios of FDG uptake under hypoxia to FDG uptake
under normoxia are presented for both hypoxia systems
in Table 1.
Cell viability
Cell viability was investigated with a Vi-Cell™ XR Cell
Viability Analyzer (Beckman Coulter) to determine
whether hypoxia at the applied conditions might cause
cell death. Cell number evaluation after 24 h cultivation
using GOX/CAT and a hypoxia chamber showed abso-
lute cell numbers of about 70% and 90% of the absolute
cell number after 24 h cultivation under normoxia.
Figure 3 Pathway analysis of hypoxia regulated genes using a hypoxia chamber and the enzymatic GOX/CAT system. The genes PGK1,
PGM1, SDS, ENO2, ALDOC, GAPDH, GPI and HKDC1 were upregulated for both hypoxia systems (Thermometer 1: Hypoxia chamber,
Thermometer 2: GOX/CAT system). Those genes are involved in glycolytic pathways. p = 4 × E-5.
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induce cell death at the applied conditions. In particular,
no significant difference was noticed in the percentage
of unvital cells (5-10%) for both normoxia and hypoxia
using GOX/CAT or chamber. Furthermore, microscopy
studies showed that the cells were still attached and
morphologically intact under the hypoxic conditions
used (data not shown).
Cell proliferation after photon irradiation
Proliferation of HNO97 cells was investigated for nor-
moxia and hypoxia after photon irradiation at a single
dose of 4 Gy. Vital cell number was measured and the
ratio vital irradiated/non-irradiated cells, was deter-
mined. This ratio represents the proportion of vital cells
after irradiation compared to the non-irradiated control.
The proliferation assays revealed higher ratios when
HNO97 cells were incubated under hypoxic conditions
(p < 0.05), indicating an enhanced cell resistance to the
applied radiation dose. This ratio was only slightly
enhanced for the slow-onset hypoxia chamber system
but was higher for the enzymatic GOX/CAT system
(p < 0.05) (Figure 6).
To determine whether different cell confluences, as
result of different cell growth rates under normoxia and
hypoxia, had an influence on irradiation outcome, prolif-
eration experiments after photon irradiation with 4 Gy
were performed for various cell confluences under nor-
moxia. These experiments revealed no significant differ-
ences in irradiation outcome within the cell number
range that was measured for normoxia, hypoxia cham-
ber and GOX/CAT (50,000 to 200,000 cells) at the time
of irradiation (Additional file 2).
Discussion
The microenviroment within a solid tumor has an
extensive influence on the outcome of cancer treatment
and the prognosis of the disease. Tumor hypoxia affects
the behaviour of tumor cells and is associated with poor
prognosis and reduced overall survival [16]. This fact
reveals the need for a detailed study of biological effects
under reduced oxygen levels. The most common techni-
que used to investigate in vitro tumor hypoxia is the
hypoxia chamber. However, this approach has
Figure 4 Quantitative RT-PCR analysis of the expression of hypoxia regulated genes. Expression of carbonic anhydrase IX (CA9) (A) and
lysyl oxidase (LOX) (B) in head and neck squamous cell carcinoma cells HNO97 under normoxia and hypoxia (2% O2) using the enzymatic GOX/
CAT system and a hypoxia chamber. mRNA levels were measured by quantitative real time PCR. Columns, average from three independent
measurements and show relative expression levels compared with cells at time point t = 0; Bars, SD. * p < 0.05.
Table 1 Glucose metabolism
Ratio FDG-uptake hypoxia/FDG-uptake
normoxia
GOX/
CAT
Chamber
6 h 1.87 1.09
24 h 2.13 1.37
Uptake of FDG in HNO97 cells after cultivation for 6 h and 24 h under
normoxic and hypoxic conditions (2% O2) using the GOX/CAT system and a
hypoxia chamber. Values of the ratio FDG-uptake under hypoxia to FDG-
uptake under normoxia.
Figure 5 Glucose metabolism.U p t a k eo fF D Gi nH N O 9 7c e l l s
incubated for 24 h under normoxic and hypoxic conditions (2% O2)
using the GOX/CAT system and a hypoxia chamber. Mean values
and standard deviation. * p < 0.05.
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equipment while it has been shown that it leads to a
slow onset of hypoxia that might influence the correla-
tion between changes in oxygen concentration and
kinetic of hypoxia dependent biological events.
An alternative to hypoxia chamber represents the
enzymatic GOX/CAT system, which has been shown
to rapidly induce in vitro hypoxia. The GOX/CAT sys-
tem has been employed in the past in various studies.
In particular, Baumann et al. have applied the enzy-
matic system for investigation of the effects of the
hypoxia-targeted prodrug KS119 [9,17]. Furthermore,
Zitta et al. used GOX/CAT for rapidly induction of
hypoxia and investigated the influence of mild
hypothermia and postconditioning with catalase on
hypoxia-mediated cell damage [18], as well as the
potential cytoprotective properties of different sevoflur-
ane conditioning strategies on a human neuronal cell
culture model [19]. In addition, Owegi et al. applied
the GOX/CAT technique to test macrophage activity
under various O2 and H2O2 concentrations, as pre-
sented under infection conditions [20]. All these stu-
dies have demonstrated a rapid decrease of oxygen
concentration using glucose oxidase and catalase but
provided only limited comparisons to the established
hypoxia chamber technique. Therefore, in the present
study we evaluated the enzymatic GOX/CAT system in
direct comparison to the established hypoxia chamber
technique for investigation of different biological
events, including gene expression, glucose uptake and
radioresistance at a defined O2 concentration.
The conditions for in vitro generation of hypoxia at a
level of 2% were carefully chosen in concert with the
results of previous studies. In particular, evaluation of
oxygen concentration using a computer-driven oxygen
electrode revealed that at the conditions used for our
experiments 2% hypoxia was rapidly induced within
15 min and maintained over 24 h [10]. Since oxygen
transport studies using hypoxia chambers have revealed
time periods of more than 3 h for equilibration of pO2
between the medium inside the plate and the gas out-
side of it, which even accelerated in the presence of
cells [8], evaluation of both systems was performed after
24 h cell cultivation under hypoxic conditions to ensure
that the observed biological events are not a result of
differences in the oxygenation level. We further chose
for our investigation a head and neck squamous cell
carcinoma (HNSCC) cell line because there is strong
evidence that hypoxia is an important microenviron-
ment factor, which influences the response of HNSCC
to therapy [21] and because the role of low oxygen ten-
sion has been extensively investigated for this cancer
entity both in preclinical and in clinical studies [22,23].
Our experiments demonstrated comparable trends for
both systems in regard to gene expression, glucose
uptake and resistance towards radiation therapy. In par-
ticular, investigation of hypoxia related genes using
microarray chip analysis in our study revealed a similar
regulation trend for most known HIF-1 target genes for
both the rapid enzymatic GOX/CAT system and the
hypoxia chamber after 24 h of hypoxia (Figure 1). The
expression of prominent hypoxia dependent genes, such
as carbonic anhydrase IX (CA9) and lysyl oxidase (LOX)
was additionally to microarray analysis quantified by
real time PCR. These genes were chosen for analysis not
only because it is known that they are hypoxia regu-
lated, but also because various studies have reported
prognostic values for them in head and neck squamous
cell carcinoma [24,25]. Microarray analysis in our study
indicated CA9 and LOX activation both in the chamber
and the enzymatic system after 24 h, while CA9 showed
stronger activation than LOX. Quantification through
real time PCR demonstrated different kinetic patterns
between the two hypoxia systems (Figure 4). Particu-
larly, although both genes were upregulated under
hypoxic conditions the upregulation peak was reached
earlier for the rapid enzymatic GOX/CAT system and
decreased thereafter, compared to the hypoxia chamber
that showed a continuous increase of gene expression
over 24 h. Our results are in concert with the results of
previous studies using the GOX/CAT system [10]. Mill-
onig et al. have shown that a fast onset of hypoxia using
the enzymatic system leads to rapid induction of HIF-1
that later disappears although the cells remain under
stable hypoxia. In contrast, cell exposure to the
same oxygen concentration using a conventional
hypoxia chamber causes a late onset and continuous
Figure 6 In vitro cell response to photon irradiation in the
72-h proliferation assay. Cells were incubated for 24 h under
normoxia and hypoxia (2% O2) using the GOX/CAT system and a
hypoxia chamber. The ratio vital treated to vital untreated cells was
determined. Mean values and standard deviation. * p < 0.05.
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results led the authors to the conclusion that HIF-1
responds rather to oxygen decrements than to absolute
hypoxia, a hypothesis that might also explain the differ-
ent kinetic patterns of the HIF-1-target genes CA9 and
LOX as demonstrated in our study.
In regard to glucose metabolism, uptake experiments
of fluorodeoxyglucose (FDG) revealed an enhanced cel-
lular uptake for both the enzymatic and the chamber
system (Figure 5), which increased with time progres-
sion (Table 1). This result is expected, since it is known
that hypoxia is associated with a reprogrammed cellular
metabolism, characterized by enhanced uptake of glu-
cose for use as anabolic and catabolic substrate. The
enhanced FDG uptake is supported by a HIF-1 depen-
dent activation of the transcription of SLC2A1 and
SLC2A3 genes, which encode the glucose transporters
GLUT1 and GLUT3 respectively. Furthermore, HIF-1
activates the transcription of the HK1 and HK2 genes,
which encode for hexokinase, an enzyme that phosphor-
ylates FDG and represents the first enzyme of the Emb-
den-Meyerhoff (glycolytic) pathway [26,27]. The role of
HIF-1 in further metabolisation of glucose has been
extensively investigated in previous studies. In particular,
it has been shown that glycolytic enzymes which meta-
bolize glucose to pyruvate, and lactate dehydrogenase A
(LDHA) which further converts pyruvate to lactate are
regulated by HIF-1, promoting ATP production through
increased anaerobic glycolysis under hypoxic conditions
[28]. The results of our study demonstrate that the new
enzymatic GOX/CAT system affects glucose metabolism
in a similar trend like the established hypoxia chamber.
FDG uptake was increased for both systems, result that
is in concert with the microarray analysis, which shows
an upregulation of genes involved in glucose metabo-
lism, such as SLC2A1, SLC2A3, HK1, HK2 and LDHA.
The slower increase of FDG uptake for the hypoxia
chamber, compared to GOX/CAT (Table 1) might be
explained by different kinetics in the expression of
HIF-1 target genes that are involved in glucose metabo-
lism, considering the fact that further HIF-1 target
genes, such as CA9 and LOX showed different expres-
sion kinetics for the two systems.
In regard to glucose metabolism, assignment of gene
expression results to biological function gene ontology
terms (GO-terms), demonstrated glycolysis to be the
most probably regulated GO-term for both systems (Fig-
ure 3). This is expected since glycolysis is known to be
the preferred route for energy production under condi-
tions of oxygen deficiency. Although our results provide
strong indications of glycolytic metabolism, further
investigation of the ratio between lactate production and
glucose consumption is needed in order to assess the
balance between glycolytic and oxidative metabolism
under normoxia and hypoxia using the GOX/CAT sys-
tem. This is important, considering the fact that cancer
cells are known to use glycolysis even under normoxic
conditions. Since glycolysis can produce ATP at higher
rates than oxidative phosphorylation [29] and tumor
cells require fast energy production in order to support
cell growth and survival, metabolic alterations in favour
of glycolysis is noticed even under normoxia [30],
demonstrating the complexity of pathways and mechan-
isms in respect to microenvironment adaptation of
tumor cells.
The enzymatic GOX/CAT system has however a criti-
cal limitation that needs to be considered in experi-
ments investigating glucose metabolism. Glucose
oxidase (GOX) does not only consume oxygen but also
leads to depletion of glucose in the incubation medium.
Previous studies investigating in vitro FDG uptake in
various cell lines have revealed that hypoglycemic condi-
tions lead to an increased FDG uptake [31,32]. Further-
more, it has been shown that the enhanced transport
activity caused by hypoglycemia is attributed to an
increased expression of GLUT1 in the cell membrane
[33]. Therefore, the GOX mediated glucose depletion
m i g h tb i a st h er e s u l t so fm e t a b o l i ce x p e r i m e n t s .T h e
substrate consumption at various settings of the GOX/
CAT system has been extensively evaluated [34]. Under
our conditions, hypoxia could be stably maintained for
about 24 h without replacing the medium and reagents,
leading to a glucose decrease of about 10% [10]. For
comparison, 5% equals the 24-hour glucose consump-
tion of about 90 million exponentially growing tumor
cells [35].
Subphysiologic levels of oxygen in the tumor lead to
an up to 3-fold increase of resistance against antineo-
plastic strategies, such as radiation therapy [36]. The
enhanced radioresistance is explained through a reduced
production of cytotoxic reactive species and promotion
of the upregulation of genes that protect the cells from
irradiation [37]. Within our s t u d yw ep e r f o r m e dp r o l i f -
eration experiments after irradiation of the cells in order
to investigate whether the enzymatic GOX/CAT system
could be used for in vitro investigation of hypoxia
related radioresistance. The comparison with the estab-
lished hypoxia chamber revealed that at O2 concentra-
tion of 2% only a slight resistance increase was noticed
for the hypoxia chamber system, while the GOX/CAT
system showed a higher resistance to photon irradiation
(Figure 6). The enhanced radioresistance for the rapid
hypoxic strategy could be explained by an increased
growth arrest in the G0/G1 phase of the cell cycle. It
has been shown in the past that one of the genes that
promote growth arrest in the G0/G1 phase via upregula-
tion of p21 is heme oxygenase 1 (HMOX1) [38]. Our
gene expression analysis revealed a strongly increased
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pared to the hypoxia chamber (Log2 of 3.5 and 0.2,
respectively), result that offers a possible explanation for
the enhanced cytoprotection that needs to be further
investigated.
The hypothesis of growth arrest through rapid hypoxia
is supported by the results of viability experiments irre-
spective of irradiation. These experiments showed lower
cell numbers for the hypoxic systems compared to nor-
moxia. Trypan blue and microscopy analysis revealed
however that the reduced cell number was not attribu-
ted to cell death. Our results might be explained by a
reduced cell division and DNA synthesis, which has
been described in previous studies using the enzymatic
model [10].
The GOX/CAT system has some limitations. Besides
the fact that GOX causes glucose depletion and there-
fore the results might be affected by substrate depriva-
t i o n ,t h ea c t i v i t yo fG O Xa l s ol e a d st ot h ep r o d u c t i o n
of D-gluconolactone, which may cause culture medium
acidification. pH measurement during our studies with
HNO97 cells revealed no significant acidification of
the DMEM medium for the investigated time period of
24 h. However, using the GOX/CAT system for
hypoxia induction on human umbilical vein endothelial
cells (HUVEC) a rapid pH decrease to a level of about
4.0-4.5 was noticed, leading to RNA degradation and
cell death (data not shown). The extracellular pH of
malignant tumors is known to be acidic, within a
range of 6.5 to 7.0, as a consequence of increased glu-
cose metabolism and poor perfusion [39], promoting
tumor cell invasion via several matrix remodeling sys-
tems, including metalloproteinases, lysosomal proteases
and hyaluronidase [40,41]. However, the strong acido-
sis measured on HUVEC cells using the GOX/CAT
system, can not only be attributed to physiologically
induced acidocis. A possible explanation is a low buffer
capacity of the HUVEC cell culture medium, which
needs to be considered in the design of experiments
using the GOX/CAT system. In order to minimize
substrate depletion and gluconolactone production two
strategies can be applied for incubation periods longer
than 24 h. The first strategy is the replacement of the
incubation medium by fresh, preequilibrated medium
and the second is the use of larger volumes of med-
ium, which will in turn increase the time to reach
stable hypoxia [34].
Finally, it should be mentioned that the GOX/CAT
system allows the additional generation and control of
hydrogen peroxide independently of the degree of
hypoxia [34,42]. Since reactive oxygen species play an
important role during tumor growth and radiation ther-
a p yo ft u m o r s ,t h i so p t i o nm a yb eh i g h l yi n t e r e s t i n g
when studying the role of transcription factors such as
HIF-1 that are both responsive to hypoxia but also reac-
tive oxygen species.
Conclusions
In conclusion, the results of our study indicate that the
GOX/CAT system might be a useful tool for the in vitro
investigation of tumor hypoxia. In comparison to the
established hypoxia chamber techniques, the GOX/CAT
approach can induce hypoxia rapidly and in a controlled
manner, while it is inexpensive and does not require
technical equipment. Despite limitations which should
be considered in the experimental design, the enzymatic
system represents an attractive and valuable alternative
for studying biological events associated with tumor
hypoxia that needs to be further investigated.
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